calendar
5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
next 91 dayslessmore
MonWedFri
5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Vestibular Stimulation
Sponsor: The First Affiliated Hospital of Bengbu Medical University. Phase: NA. Conditions: Coronary Disease
Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Epilepsy
Sponsor: Jacqueline Garcia, MD. Phase: PHASE1. Conditions: Acute Myeloid Leukaemia (AML), Leukemia, Blood Cancer, Blood Cancers
Sponsor: The National Center on Addiction and Substance Abuse at Columbia University. Phase: NA. Conditions: Internalizing Disorders, Substance Use Disorders
Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: Relapsed/Refractory Acute Myeloid Leukemia(AML)
Sponsor: Gilgamesh Pharmaceuticals. Phase: PHASE2. Conditions: Major Depressive Disorder
Sponsor: Gan & Lee Pharmaceuticals.. Phase: PHASE1. Conditions: Prostate Cancer
Sponsor: Poznan University of Medical Sciences. Phase: NA. Conditions: Osteoarthritis Shoulder
Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Cystic Fibrosis
Sponsor: Fundación Universitaria del Area Andina. Phase: NA. Conditions: Kidney Transplant Recipients, Metabolic Syndrome, Cardiovascular Risk Factors
Sponsor: Second Xiangya Hospital of Central South University. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer, Immune Checkpoint Inhibitors (ICIs)
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE3. Conditions: Renal Cell Carcinoma
Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Small Cell Lung Carcinoma, Large Cell Neuroendocrine Carcinoma of the Lung, Neuroendocrine Prostate Cancer, Gastroenteropancreatic Neuroendocrine Carcinoma
Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: Breast Cancer Female
Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Epilepsy
Sponsor: University of Michigan. Phase: NA. Conditions: Sleep, Pregnancy Complications
Sponsor: Yonsei University. Phase: . Conditions: Drug Hypersensitivity
Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology. Phase: PHASE1. Conditions: Liver Cirrhosis
Sponsor: Hoffmann-La Roche. Phase: PHASE2. Conditions: Renal Cell Carcinoma
Sponsor: UMC Utrecht. Phase: NA. Conditions: Gastric Cancer
Sponsor: Kafkas University. Phase: NA. Conditions: Hypertension, Mobile Application, Blood Pressure Control, Treatment Adherence, Self-Efficacy
Sponsor: The National Brain Mapping Laboratory (NBML). Phase: NA. Conditions: Multiple Sclerosis
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Renal Impairment, End-stage Kidney Disease, Healthy Participants
Sponsor: Georgia Tsaousi. Phase: PHASE4. Conditions: Brain Tumor, Metabolic Disturbance, Inflammatory Response, Oxygen Deficiency
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: . Conditions: Migraine
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)
Sponsor: Antalya City Hospital. Phase: NA. Conditions: Breast Cancer, Lymph Node Dissection, Postoperative Pain, Mastectomy
Sponsor: Nanfang Hospital, Southern Medical University. Phase: NA. Conditions: Pathology Foundation Model
Sponsor: Hoffmann-La Roche. Phase: . Conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
Sponsor: University Health Network, Toronto. Phase: PHASE2. Conditions: Prostate Cancer, Prostatectomy
Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Colon Adenocarcinoma, Colorectal Carcinoma, Rectal Adenocarcinoma
Sponsor: Instituto de Investigación Biomédica de Salamanca. Phase: PHASE3. Conditions: Small Cell Lung Carcinoma
Sponsor: National Institute on Drug Abuse (NIDA). Phase: EARLY_PHASE1. Conditions: Normal Physiology
Sponsor: Nikolaj Frost MD. Phase: PHASE4. Conditions: Non-Small Cell Lung Cancer Metastatic
Sponsor: KK Women's and Children's Hospital. Phase: . Conditions: Pediatrics, Intensive Care Unit, Critical Illness
Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Phase: PHASE3. Conditions: Epilepsy, Focal
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Consciousness Disorders, Disorders of Consciousness Due to Severe Brain Injury
Sponsor: Kathmandu University School of Medical Sciences. Phase: NA. Conditions: Blood Loss, Postoperative, Blood Loss, Surgical, Femoral Fracture, Tibial Fracture
Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Pain
Sponsor: Catholic University of the Sacred Heart. Phase: NA. Conditions: Obesity (BMI > 35)
Sponsor: Central Hospital, Nancy, France. Phase: . Conditions: Antisynthetase Syndrome
Sponsor: Bayer. Phase: PHASE2. Conditions: High-Risk Localized Prostate Cancer
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Activated PI3K Delta Syndrome
Sponsor: University of Stirling. Phase: NA. Conditions: Health Behavior
Sponsor: Ohio State University. Phase: NA. Conditions: Suicide Prevention
Sponsor: Charite University, Berlin, Germany. Phase: NA. Conditions: Psychosis, Psychotic Disorders, Primary Psychotic Disorders, Schizophrenia Spectrum Disorders, Schizophrenia, Schizoaffective Disorder
Sponsor: Boston Children's Hospital. Phase: . Conditions: Intestinal Failure, Hypoglycemia, Hyperglycemia
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: . Conditions: Glaucoma, OCTA, Choroid
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma